Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Evolutionary Relationships through Genome Comparisons02:54

Evolutionary Relationships through Genome Comparisons

5.7K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
5.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Gene Duplication and Divergence02:37

Gene Duplication and Divergence

6.0K
The seminal work of Ohno in 1970 popularized the idea of gene duplication and divergence. DNA sequence comparison studies reveal that a large portion of the genes in bacteria, archaebacteria, and eukaryotes was  generated by gene duplication and divergence, indicating its critical role in evolution.
The duplicated copies of the gene are called Paralogs. Paralogs with similar sequences and functions form a gene family. Across several species, a large number of gene families are...
6.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

10.8K
Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of host use in Culex mosquitoes and their implications for arbovirus transmission dynamics in urban environments.

Medical and veterinary entomology·2026
Same author

Minimally Invasive/Robotic Surgery for Colorectal Liver Metastasis.

Surgical oncology clinics of North America·2026
Same author

Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant Pairs.

International journal of cancer·2026
Same author

Surgical Quality at Rural Hospitals After Private Equity Acquisition.

Annals of surgery·2026
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biology·2026
Same author

Ecological drivers of St. Louis encephalitis virus activity in mosquito communities from Argentine agroecosystems.

Medical and veterinary entomology·2026

Related Experiment Video

Updated: Jun 4, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K

Combining evolution and protein language models for an interpretable cancer driver mutation prediction with D2Deep.

Konstantina Tzavella1, Adrian Diaz1, Catharina Olsen1,2,3

  • 1Interuniversity Institute of Bioinformatics (IB2), Université Libre de Bruxelles, Vrije Universiteit Brussel (ULB-VUB), Triomflaan, Brussels 1050, Belgium.

Briefings in Bioinformatics
|December 21, 2024
PubMed
Summary

D2Deep, a new AI tool, accurately identifies cancer-driving mutations using protein language models and evolutionary data. It overcomes limitations of existing methods, offering interpretable results for clinical use.

Keywords:
evolutionary informationmachine learningmutation effect predictionprotein large language models

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.6K

Related Experiment Videos

Last Updated: Jun 4, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.6K

Area of Science:

  • Computational Biology
  • Genomics
  • Bioinformatics

Background:

  • Distinguishing cancer driver mutations from passenger mutations is crucial but challenging.
  • Existing homology-based predictors have biases and limitations in cancer biology.
  • Protein language models show promise but haven't been applied at scale for cancer driver mutation prediction, often lacking interpretability.

Purpose of the Study:

  • Introduce D2Deep, an AI method for large-scale cancer driver mutation prediction.
  • Address limitations of current predictors, including biases and lack of interpretability.
  • Leverage protein language models and evolutionary information for accurate mutation identification.

Main Methods:

  • Developed D2Deep, combining a general protein language model with protein-specific evolutionary information.
  • Utilized exclusively sequence information for prediction.
  • Trained the model on a balanced somatic dataset to mitigate hotspot mutation biases.

Main Results:

  • D2Deep outperforms state-of-the-art predictors in identifying cancer driver mutations.
  • The method captures complex epistatic changes, correlating with clinical mutations for interpretation.
  • Demonstrated versatility with successful non-cancer mutation prediction.

Conclusions:

  • D2Deep offers a powerful, interpretable solution for cancer driver mutation prediction.
  • The AI model mitigates biases and enhances clinical utility.
  • Predictions and confidence scores are available to aid clinical interpretation and mutation prioritization.